FDA Seeking Comments on Farm Antibiotic Use
USAgNet - 09/19/2016
The U.S. Food and Drug Administration is seeking public comments on setting use periods for medically important antimicrobials--those important for treating human diseases--used in livestock production. FDA's Guidance for Industry 213 limits the use of such
drugs to therapeutic purposes under the oversight of a veterinarian. Guidance 213, starting Jan. 1, 2017, also will eliminate the use in livestock of medically important antibiotics for growth promotion purposes.
While the guidance outlines how medically important antimicrobial drugs administered to animals through feed and water will have a defined amount of time they can be used, it does not address some currently approved therapeutics that lack on their labels
defined durations of use. FDA is requesting information on establishing appropriately targeted durations of use for products that donít have them.
Specifically, FDA wants to obtain information on the underlying diseases requiring drugs for therapeutic purposes and periods when livestock or poultry are at risk for developing the diseases.
NPPC will submit comments and work with FDA to successfully implement Guidance 213.